Trial Profile
A randomized, double-blind, positive- and placebo-controlled, parallel-design trial of Lacosamide in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Jul 2016
Price :
$35
*
At a glance
- Drugs Lacosamide (Primary) ; Moxifloxacin
- Indications Epilepsy; Seizures
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 08 Jul 2016 New trial record